Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications is a research paper published in Frontiers in Bioengineering and Biotechnology (2020). On theSindex it has a DataRank of 0. It has been cited 124 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1R56CA213859
National Cancer Institute
Grant: F31CA232705
Cancer Prevention and Research Institute of Texas
Grant: RP170466
National Institutes of Health
Grant: 1F31CA232705-01
Targeting the JAK/STAT3 Pathway in Triple-Negative Breast Cancer Using Biomimetic Nanoparticles
National Institutes of Health
Grant: 1R56CA213859-01A1
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
FWCI
4.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals